Kailera Therapeutics is trading 5.94% up in pre-market at $19.99 after announcing Nur Nicholson as chief technology officer on August 11, 2026, effective August 31.
- Second-quarter 2026 earnings are scheduled after the market closes on August 12, 2026, potentially supporting pre-market interest.
- Nasdaq futures are up 0.64% ahead of the Consumer Price Index report, with broader sentiment modestly positive.
- No earnings results or stronger company-specific catalyst were available before the open.